市場調查報告書

全球細胞解離市場:產品,組織(結締組織,表皮組織),終端用戶,各地區(2018年∼2023年)

Global Cell Dissociation Market - Segmented by Product, Tissue (Connective Tissue, Epithelial Tissue and Other Tissues), End-User and Geography - Growth, Trends and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 707237
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
全球細胞解離市場:產品,組織(結締組織,表皮組織),終端用戶,各地區(2018年∼2023年) Global Cell Dissociation Market - Segmented by Product, Tissue (Connective Tissue, Epithelial Tissue and Other Tissues), End-User and Geography - Growth, Trends and Forecast (2018 - 2023)
出版日期: 2018年08月01日內容資訊: 英文 110 Pages
簡介

全球細胞解離市場在2018年到2023年整個預測期間內,預測將以12%的年複合成長率成長。

本報告提供全球細胞解離市場調查,提供市場概要,各產品·組織·終端用戶·地區別市場規模的變化與預測,市場趨勢,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 市場動態

  • 成長要素
    • 生物醫藥品企業研究開發活動的擴大
    • 對癌症研究有利的資金籌措方案
  • 阻礙因素
    • 組織·細胞治療的成本高
  • 市場機會
  • 課題

第7章 市場分析:各市場區隔

  • 各產品
    • 酵素的解離產品
    • 非酵素的解離產品
    • 設備·週邊設備
  • 不同組織
    • 結締組織
    • 表皮組織
    • 其他組織
  • 各終端用戶
    • 製藥·生物科技企業
    • 學術研究機關
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第8章 企業簡介和競爭情形

  • American Type Culture Collection
  • Becton Dickinson & Company
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Himedia Laboratories
  • Merck KGaA
  • Miltenyi Biotec
  • Pan-Biotech
  • Stemcell Technologies
  • Thermo Fischer Scientific Inc.

第9章 市場未來展望

目錄
Product Code: 62794

Cell Dissociation Market Overview

The global cell dissociation market is projected to grow at a CAGR of approximately 12% during the forecast period (2018-2023). Cell dissociation refers to the act of isolating single-cell, usually in a suspension medium from adherent mono-layer of cells for developing differentiated cell lines in-vivo through proliferation or for research of biochemical properties of cell mono-layer itself.

Increasing R&D Activities in Biopharmaceutical Companies

The total worldwide R&D spending of pharmaceutical and biotechnology companies increased from USD 108 billion in 2006 to USD 141 billion in 2015. The high investment in R&D activities of biopharmaceutical companies is indicative of the high return on investment which biopharmaceuticals make upon the commercial release of their pipeline drugs and therapeutics. Increasing prevalence of chronic diseases caused due to lifestyle induced factors have increased the demand for novel therapeutic agents which in turn has directly led to increased spending by biopharmaceutical firms in R&D activities. Cell dissociation is an indispensable activity in biopharmaceutical research as it is involved directly in drug development and pathology elucidation. Consequently, the increased spending by biopharmaceutical companies in R&D activities is driving the growth of global cell dissociation market. Other factor contributing to the growth of global cell dissociation market includes favorable funding of scenario for cancer research.

High Cost of Tissue and Cell Based Procedures

The average cost of functional restoration surgery and soft-tissue reconstruction in US was estimated to be between 9000 to 13,000 USD. The estimated figures for soft-tissue reconstruction is higher for lower- body extremities when compared to upper-body extremities. In addition to this, allografts are often scarce and very low quantities are synthesized in comparison to the economic resources invested in harvesting allografts. Consequently the cost of allografts themselves are subject to price fluctuation depending on their availability. High cost of soft-tissue procedures is therefore limiting the growth of the global cell dissociation market.

North America has the Largest Share in the Cell Dissociation Market

The global cell dissociation market has been segmented into five major regions, viz. North America, Europe, Asia Pacific, Middle East & Africa, and South America. Driven by the developed country of the U.S., North America is dominated the global cell dissociation market in 2017, due to factors such as increased spending by biopharmaceuticals in R&D activities. Furthermore, increasing demand for cancer treatments has prompted the governments in major economies of North America to accelerate the research in oncology, which is in turn is also also boosting the growth of the cell dissociation market in North America.

Non-Enzymatic Dissociation Products Expected to Exhibit Highest Growth

The global cell dissociation market has been segmented on the basis of products into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Non-enzymatic dissociation products provide cell samples which are free from protein contamination. Non- enzymatic approaches are easier to employ when compared to enzymatic approaches and also chances of toxicity and contamination are reduced in non-enzymatic cell dissociation. In the current market there is widespread prevalence of enzymatic dissociation products, particularly trypsin. But over the forecast period, non-enzymatic dissociation product category will register fastest growth primarily due to differential advantages it provides over enzyme based dissociation products.

Key Developments in Cell Dissociation Market

Jul 2018: American Type Culture Collection (ATCC), a premier global biological materials resource and standards organization and also the leading supplier of authenticated cells and advanced cell models, announced the commercial availability of its new PCR-based service to detect mycoplasma contamination in cell cultures. This growing service portfolio is part of a larger effort by ATCC to support the authentication of cell lines used in basic and translational research.

Major Players: AMERICAN TYPE CULTURE COLLECTION, BECTON DICKINSON & COMPANY, F. HOFFMANN-LA ROCHE LTD., GE HEALTHCARE, HIMEDIA LABORATORIES, MERCK KGAA, MILTENYI BIOTEC, PAN-BIOTECH, STEMCELL TECHNOLOGIES, and THERMO FISCHER SCIENTIFIC INC. among others.

Reasons to Purchase Cell Dissociation Market Report

Current and future global cell dissociation market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3-month analyst support along with the Market Estimate sheet (in Excel).

Customization of Cell Dissociation Market Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Cell Dissociation Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyer
    • 5.2.3 Degree of Competition
    • 5.2.4 Threat of Substitution
    • 5.2.5 Threat of New Entrants

6. Cell Dissociation Market Dynamics

  • 6.1 Drivers
    • 6.1.1 Increasing R&D Activities in Biopharmaceutical Companies
    • 6.1.2 Favorable Funding Scenario for Cancer Research
  • 6.2 Restraints
    • 6.2.1 High cost of Tissue and Cell Based Procedures
  • 6.3 Opportunities
  • 6.4 Challenges

7. Cell Dissociation Market Segmentation

  • 7.1 By Product
    • 7.1.1 Enzymatic Dissociation Products
    • 7.1.2 Non-Enzymatic Dissociation Products
    • 7.1.3 Instruments & Accessories
  • 7.2 By Tissue
    • 7.2.1 Connective Tissue
    • 7.2.2 Epithelial Tissue
    • 7.2.3 Other Tissues
  • 7.3 By End-User
    • 7.3.1 Pharmaceutical & Biotechnology Companies
    • 7.3.2 Research & Academic Institutes
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America Cell Dissociation Market (2018-2023)
      • 7.4.1.1 US Cell Dissociation Market (2018-2023)
      • 7.4.1.2 Canada Cell Dissociation Market (2018-2023)
      • 7.4.1.3 Mexico Cell Dissociation Market (2018-2023)
    • 7.4.2 Europe Cell Dissociation Market (2018-2023)
      • 7.4.2.1 UK Cell Dissociation Market (2018-2023)
      • 7.4.2.2 Germany Cell Dissociation Market (2018-2023)
      • 7.4.2.3 France Cell Dissociation Market (2018-2023)
      • 7.4.2.4 Italy Cell Dissociation Market (2018-2023)
      • 7.4.2.5 Spain Cell Dissociation Market (2018-2023)
      • 7.4.2.6 Rest of Europe
    • 7.4.3 Asia-Pacific Cell Dissociation Market (2018-2023)
      • 7.4.3.1 China Cell Dissociation Market (2018-2023)
      • 7.4.3.2 India Cell Dissociation Market (2018-2023)
      • 7.4.3.3 Japan Cell Dissociation Market (2018-2023)
      • 7.4.3.4 Australia Cell Dissociation Market (2018-2023)
      • 7.4.3.5 South Korea Cell Dissociation Market (2018-2023)
      • 7.4.3.6 Rest of Asia-Pacific
    • 7.4.4 Middle East & Africa Cell Dissociation Market (2018-2023)
      • 7.4.4.1 GCC Cell Dissociation Market (2018-2023)
      • 7.4.4.2 South Africa Cell Dissociation Market (2018-2023)
      • 7.4.4.3 Rest of Middle East & Africa
    • 7.4.5 South America Cell Dissociation Market (2018-2023)
      • 7.4.5.1 Brazil Cell Dissociation Market (2018-2023)
      • 7.4.5.2 Argentina Cell Dissociation Market (2018-2023)
      • 7.4.5.3 Rest of South America

8. Company Profiles & Competitive Landscape

  • 8.1 American Type Culture Collection
  • 8.2 Becton Dickinson & Company
  • 8.3 F. Hoffmann-La Roche Ltd.
  • 8.4 GE Healthcare
  • 8.5 Himedia Laboratories
  • 8.6 Merck KGaA
  • 8.7 Miltenyi Biotec
  • 8.8 Pan-Biotech
  • 8.9 Stemcell Technologies
  • 8.10 Thermo Fischer Scientific Inc.

List Not Exhaustive

9. Cell Dissociation Market Future